Friday, May 30, 2014

Top 10 Quality Stocks To Buy For 2015

Top 10 Quality Stocks To Buy For 2015: Warner Chilcott plc(WCRX)

Warner Chilcott Public Limited Company, a specialty pharmaceutical company, together with its subsidiaries, engages in the development, manufacture, and promotion of branded pharmaceutical products focusing on the women?s healthcare, gastroenterology, dermatology, and urology markets in North America and western Europe. Its principal products include ACTONEL for the prevention and treatment of postmenopausal osteoporosis; ATELVIA for the treatment of postmenopausal osteoporosis; LOESTRIN 24 FE and LO LOESTRIN FE, which are oral contraceptives for the prevention of pregnancy; ESTRACE cream, a vaginal cream for the treatment of vaginal and vulvar atrophy; ASACOL for the treatment of ulcerative colitis for orally administered 5-aminosalicylic acid products and maintenance of remission; ASACOL HD for the treatment of moderately active ulcerative colitis; DORYX, a tetracycline-class oral antibiotic for the treatment of severe acne; and ENABLEX for the treatment of overactive b ladder. The company markets its products and services through wholesale pharmaceutical distributors, and retail drug store chains. It has a strategic collaboration agreement with Sanofi-Aventis U.S. LLC. Warner Chilcott Public Limited Company was founded in 1968 and is headquartered in Dublin, Ireland.

Advisors' Opinion:
  • [By Dan Caplinger]

    Tomorrow, Warner Chilcott (NASDAQ: WCRX  ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed kneejerk reaction to news that turns out to be exactly the wrong move.

  • [By Sean Williams]

    What: Shares of Warn! er Chilcott (NASDAQ: WCRX  ) , a branded pharmaceutical company focused on women's health care, shot higher by as much as 20% after the company reported its first-quarter earnings results, and on news that it could be a buyout target.

  • [By Rich Smith]

    On Friday, shares of branded pharmaceutical manufacturer Warner Chilcott (NASDAQ: WCRX  ) jumped 20% in response to rumors that the company was in talks to sell itself to larger rival Actavis (NYSE: ACT  ) . Warner also reported steady earnings, where a decline had been expected, and reiterated full-year guidance.

  • source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-quality-stocks-to-buy-for-2015.html

No comments:

Post a Comment